Paper649291
The expectation of free and fixed particles in urinary stone disease.
Finlayson B and 1 other. Invest Urol, 1978. Cited by 277 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The expectation of free and fixed particles in urinary stone disease. Papers, record 649291. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/649291
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Urinary Calculi | Major topic |
| Humans | |
| Kidney | |
| Kidney Calculi | |
| Kidney Pelvis | |
| Kidney Tubules | |
| Models, Biological | |
| Oxalates | |
| Urinary Bladder Calculi |
Source PubMed
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 277 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42988848 | Kidney stones. | Nat Rev Dis Primers | 2026 | https://conductscience.org/library/papers/42988848 | PubMed |
| 41587311 | Intercalated bacterial biofilms are intrinsic internal components of calcium-based kidney stones. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41587311 | PubMed |
| 40788511 | Apoptosis, ferroptosis, necrosis, necroptosis and pyroptosis in the formation of calcium oxalate kidney stones. | Urolithiasis | 2025 | https://conductscience.org/library/papers/40788511 | PubMed |
| 40353475 | Recent Progression and Treatment Approaches for the Kidney Stone Management. | Curr Drug Targets | 2025 | https://conductscience.org/library/papers/40353475 | PubMed |
| 39932538 | Advances in the mechanism of urinary proteins in calcium oxalate kidney stone formation. | Urolithiasis | 2025 | https://conductscience.org/library/papers/39932538 | PubMed |
| 39174582 | Tumour lysis syndrome. | Nat Rev Dis Primers | 2024 | https://conductscience.org/library/papers/39174582 | PubMed |
| 38089442 | Oxalate Nephropathy and the Mechanism of Oxalate-Induced Kidney Injury. | Kidney Dis (Basel) | 2023 | https://conductscience.org/library/papers/38089442 | PubMed |
| 37671841 | Chemical Modification of Tiopronin for Dual Management of Cystinuria and Associated Bacterial Infections. | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/37671841 | PubMed |
| 37538166 | Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence. | Asian J Urol | 2023 | https://conductscience.org/library/papers/37538166 | PubMed |
| 37314585 | Determinants on urinary excretion of oxalate and other key factors related to urolithiasis among patients with chronic kidney disease: a single center study. | Urolithiasis | 2023 | https://conductscience.org/library/papers/37314585 | PubMed |
| 36329164 | Pediatric urolithiasis: what can pediatricians expect from radiologists? | Pediatr Radiol | 2023 | https://conductscience.org/library/papers/36329164 | PubMed |
| 35753725 | Mechanism and influencing factors of crystal-cell interaction in the formation of calcium oxalate stones. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2022 | https://conductscience.org/library/papers/35753725 | PubMed |
| 34907378 | The genetics of kidney stone disease and nephrocalcinosis. | Nat Rev Nephrol | 2022 | https://conductscience.org/library/papers/34907378 | PubMed |
| 34031587 | Human kidney stones: a natural record of universal biomineralization. | Nat Rev Urol | 2021 | https://conductscience.org/library/papers/34031587 | PubMed |
| 33051515 | Essential roles of oncostatin M receptor β signaling in renal crystal formation in mice. | Sci Rep | 2020 | https://conductscience.org/library/papers/33051515 | PubMed |
| 30470787 | Current insights into the mechanisms and management of infection stones. | Nat Rev Urol | 2019 | https://conductscience.org/library/papers/30470787 | PubMed |
| 30213974 | Geobiology reveals how human kidney stones dissolve in vivo. | Sci Rep | 2018 | https://conductscience.org/library/papers/30213974 | PubMed |
| 29962797 | In Vitro Antilithiatic Potential of Kalanchoe pinnata, Emblica officinalis, Bambusa nutans, and Cynodon dactylon. | J Pharm Bioallied Sci | 2018 | https://conductscience.org/library/papers/29962797 | PubMed |
| 29619876 | Inhibitory effects of taraxasterol and aqueous extract of Taraxacum officinale on calcium oxalate crystallization: in vitro study. | Ren Fail | 2018 | https://conductscience.org/library/papers/29619876 | PubMed |
| 29428569 | A continuum of mineralization from human renal pyramid to stones on stems. | Acta Biomater | 2018 | https://conductscience.org/library/papers/29428569 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/649291
GET https://conductscience.org/api/papers/v1/649291/cited_by?page=2